fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

Antiviral drugs used so far for treating COVID-19 has been focusing on targeting specific viral species. For effective treatment, scientists have found cellular nanosponges to restrict virus replication. With the increasing number of COVID-19 cases every day, the hunt for treatment or vaccine is inevitable. So far the experimental studies on antiviral drugs are being used to treat a specific ...

As the world fights a battle of survival against a deadly virus, thousands of researchers have been on the path to find a vaccine. One such, Patanjali, an Ayurvedic consumer goods company, on Tuesday, launched 'Coronil and Swasari', what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 percent favorable results during clinical ...

As the world scrambles to stem the pandemic, the US government top infectious disease expert has provided some hope of some vaccine being ready as early as November even as epidemiologists warn the novel coronavirus will not go away entirely and is likely to remain for the upcoming years to come. Scientists stated that the virus might become endemic like ...

Cipla announced the launch of remdesivir under its brand name CIPREMI. Remdesivir is US FDA approved Emergency Use Authorisation (EUA) treatment for adult and pediatric patients hospitalized with suspected or laboratory-confirmed COVID-19 infection. In May, Gilead Sciences extended a voluntary non-exclusive license to Cipla to manufacture and market Cipla’s generic version of remdesivir called CIPREMI. Cipla received regulatory approval by ...

The early medical response to the Covid-19 pandemic in the United States was limited in part by the availability of testing. Health care workers collected a swab sample from the patients’ oropharynx or nasopharynx according to testing guidelines for the SARS-CoV-2 virus. This procedure potentially increased the risk of transmission of the virus to health care workers who lacked sufficient ...

An Oxford professor has claimed that the entire British population could be vaccinated against the novel coronavirus by the end of this year. According to Oxford University trial leader, Sir John Bell, a COVID-19 vaccine could possibly be available by autumn, prompting excitement that a safe jab against the SARS-CoV-2 virus may be available by the end of 2020. The ...

According to a recent update on Wednesday from Xinhua news agency, The European Union (EU) is planning to accelerate the development of COVID1-9 vaccines through advance purchase agreements with promising medical companies, the bloc announced. In order to support companies in the swift development and production of a vaccine, the European Commission will enter into agreements with individual vaccine producers. ...

After the declaration of the coronavirus as a pandemic, six months have passed. After which it has spread its coarse world-wide and soon enough it will be said to have a vaccine. The discovery of a common low-cost steroid drug, Dexamethasone came as the most promising developments recently, even as over 110 groups work round the clock to search for ...

China, in a bid to stem the spread of the contagion, has begun the mass testing of hundreds of people who had visited a Beijing wholesale market which sparked a fresh bout of coronavirus cases even as the country reported 67 new COVID-19 infections including 42 in the capital. The market became a hotspot after it reported several new COVID-19 ...

Reaching a level of desperation, humans need to settle for a vaccine which though cannot help a person from contracting the virus, can help in curing patients.  For several months now, the recent novel COVID virus has affected millions of people and has claimed thousands of lives. Ever since its first eruption in Wuhan, China late last year, scientists have ...